Inclusion Criteria:  Patients between 18 and 61 years Diagnosis between 2010 and 2019 Core binding factor and/or NPM1 acute myeloid leukemia First complete remission after induction therapy Measurable residual disease measurement after end of consolidation therapy  Exclusion Criteria:  Acute promyelocytic leukemia Allogeneic stem cell transplantation in CR1